FDA Announces Emergency Authorization for Covid-19 Treatment
The US Food and Drug Administration issued an emergency use authorization for the use of convalescent plasma to treat Covid-19 on Sunday, saying the "known and potential benefits of the product outweigh the known and potential risks of the product."
Trump deemed the treatment a “major breakthrough."
According to the FDA, more than 70,000 patients have been treated using convalescent plasma. Convalescent plasma is made using the blood of people who have recovered from coronavirus infections.
Said Trump at a White House Press Briefing, "Today I am pleased to make a truly historic announcement in our battle against the China virus that will save countless lives...Today's action will dramatically increase access to this treatment."
Photo Credit: qimono